GL1X · GenesisL1 explorer

MolNFT v1 · #378135 · protein

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (C0RGD9)

C0RGD9: “AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (C0RGD9)”. 2 pockets (best druggability 0.82). MolNFT v1 #378135 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
C0RGD9
Type
protein
Length
411 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xf87a97E0A4bB354D834857B14296240B167cbe70
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
C0RGD9
Pockets
2 · best druggability 0.82

Structure

1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein41140% helix, 17% strandC0RGD9

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11760.820.9733empty
23480.690.8242empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.